NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Nexentis Technologies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.64−0.00 (-0.73%)
Close on Oct 19, 2026
- Market cap
- $522.65K
- P/E (TTM)
- –
- Dividend yield
- –
Nexentis Technologies Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | TTM Q3 22 | TTM Q2 22 | TTM Q1 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $171.00K | – | – | $139.42K | $142.00K | $169.25K | $169.25K | $169.25K | $163.64K | $152.73K | $152.73K | $152.73K | 81.4% | +20.4% |
| Israel | $31.00K | $32.41K | $24.08K | $9.64K | $10.00K | $20.71K | $24.01K | $24.01K | $30.00K | $29.22K | $26.88K | – | 14.8% | +210.0% |
| Peru | $8.00K | – | – | – | – | – | – | – | – | – | – | – | 3.8% | – |
| Mexico | – | – | – | – | $110.00K | $144.77K | $192.70K | $187.17K | $154.43K | $177.30K | $199.77K | $223.09K | – | – |
| Türkiye | – | – | – | – | $1.00K | – | – | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Nexentis Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.